Company news
Hemostemix Inc (TSXV:HEM) news
Hemostemix Inc news releases on 6ix. Latest, Sep 3, 2025: Howie's 17+ Years After VesCell(TM): Following Hemostemix's Heart Patients
Press releases — page 2
Howie's 17+ Years After VesCell(TM): Following Hemostemix's Heart Patients
September 3, 2025
Hemostemix Announces Financing Plans for VesCell(TM) Treatment
August 28, 2025
Hemostemix's Boots on the Ground in Florida
August 26, 2025
Hemostemix's Social Media for Investors and Florida's No-Option Patients
August 20, 2025
Hemostemix Announces Its AI Strategy
August 19, 2025
Hemostemix's Expands its Marketing Team Focused on Sales in Florida
August 14, 2025
Hemostemix Contracts Empire Market Ventures to Increase Market Awareness
August 12, 2025
Hemostemix Increases Previously Closed Private Placement to $3,000,000
July 31, 2025
Cells: Hemostemix ACP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants
July 31, 2025
Hemostemix Closes $2,969,600 Private Placement
July 24, 2025
Hemostemix Closes Sale of 23rd ACP-01 Therapy Convertible Debenture
July 23, 2025
Hemostemix Closing $3,000,000 Private Placement
July 17, 2025
Hemostemix Oversubscribed, Closing $2,700,000 Private Placement and Settles $400,000 of Debt at $0.20 per Share
July 9, 2025
Hemostemix Closes $469,366 Private Placement
July 4, 2025
Hemostemix Announces its 10th Publication: A Molecular Strategy for the Treatment of Heart Failure: Response to BioCardia's Cardiamp Heart Failure Trial
July 3, 2025
Hemostemix's VesCell Sales are Legal in Florida as it Pivots to Allow Non-FDA Approved Stem Cell Treatments!
July 2, 2025
Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch
June 27, 2025
Hemostemix Announces Lead Order of $1,500,000 and the Full Repayment of $2,500,000 Convertible Debenture
June 26, 2025
Hemostemix Closes Private Placement of $469,366
June 17, 2025
Hemostemix Presents at TERMIS 2025, Freiburg, Germany
May 20, 2025
Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
May 12, 2025
Hemostemix at Invest Stuttgart
May 8, 2025
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
April 23, 2025
Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
March 17, 2025
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
March 14, 2025
Life Sciences Investor Forum Agenda Announced for March 13th
March 12, 2025
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
March 6, 2025
Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture
March 5, 2025
RETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor Technologies
February 20, 2025
Hemostemix Licenses CytoImmune's BioReactor Technologies
February 19, 2025
Hemostemix Provides Corporate Update
February 12, 2025
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
February 11, 2025
Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors
February 10, 2025
CytoImmune Subscribes for 1,634,466 Hemostemix Common Shares
February 4, 2025
Hemostemix Expands to the Dominican Republic
February 3, 2025
Hemostemix Announces First Sales Orders for ACP-01
January 29, 2025
Hemostemix Up-lists to TradeGateExchange in Germany
January 27, 2025
Hemostemix Up-Lists to OTCQB While it Presents its Global Scale-Up Strategy at Two Investor Conferences in Puerto Rico
January 23, 2025
Hemostemix Announces Grant of Stock Options
January 22, 2025
Hemostemix Presents at Puerto Rico Investor Summits: Showcasing Global Scale-Up Strategy and Economic Impact
January 20, 2025
Hemostemix Settlement via Depository Trust Company Plus OTCQB Update
January 13, 2025
Hemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-Up
January 9, 2025
Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% Reimbursement of R&D Expenses in Cash
January 6, 2025
Hemostemix is Up-Listing in the USA to Generate Liquidity
January 2, 2025
Hemostemix's Social Media Awareness of "Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
December 31, 2024
Hemostemix Drives Social Media Awareness of Its Regenerative Medicine Treatments
December 17, 2024
Hemostemix Announces $2,725,982 Update to Second Closing
December 3, 2024
Hemostemix Announces $2,675,981 Private Placement Including Second Tranche of $833,258
November 28, 2024
Hemostemix Announces ACP-01 Treatment-Purchase Available with Social Media Campaign Underway
November 25, 2024
Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement
October 31, 2024